Combination of two monoclonal antibodies with SOCS1 N‐ and C‐terminal binding sites to address SOCS1 status in B cells and B‐cell lymphoma
Sign Up to like & getrecommendations! Published in 2021 at "European Journal of Haematology"
DOI: 10.1111/ejh.13730
Abstract: Accumulating studies show that the tumour suppressor SOCS1 is one of the most frequently mutated genes in lymphomas, often affecting the coding sequence of SOCS1 protein. Depending on the type of mutation and lymphoma concerned,… read more here.
Keywords: antibodies socs1; combination two; two monoclonal; terminal binding ... See more keywords